Wound-Healing Genes in Flies Bode Well for Humans
News Apr 26, 2013
Their discovery, detailed this week in the open-access journal PLoS ONE, was made in the laboratory fruit fly Drosophila. But the biologists say many of the same genes that regulate biological processes in the hard exoskeleton, or cuticle, of Drosophila also control processes in human skin. That makes them attractive candidates for new kinds of wound-healing drugs or other compounds that could be used to treat skin ailments.
“Many of the key molecules and proteins involved in Drosophila wound healing are involved in mammalian wound healing,” says Rachel Patterson, the first author who published the paper with Michelle Juarez and William McGinnis, a professor of biology and interim dean of the Division of Biological Sciences. “The genetics of Drosophila are not as complicated as mammalian genetics, so it’s easier to attribute specific biological functions to individual genes.”
By puncturing the cuticle and epidermis of fruit fly embryos in their experiments, the researchers examined 84 genes that are turned on and 78 that are turned off as the fly embryo responds to healing. From these 162 genes, they identified eight genes that are expressed at either very low levels or not at all in most cells during development, but are activated near the puncture wounds.
The researchers were surprised to discover that an immune response begins as soon as the flies’ cuticles and epidermis were punctured, releasing antimicrobial peptides and other compounds that prepare the embryo should bacteria or fungi enter the site of injury. The key to their technique was the use of trypsin, a member of a family of enzymes called serine proteases, which activates genes involved in wound healing. The next step is to see if these genes play a comparable role in humans.
“I think one amazing application of our studies may be to build a better bandage — containing compounds to promote would healing,” said Juarez, a former postdoctoral fellow in McGinnis’s lab who is now an assistant medical professor at the City College of New York.
“Perhaps our results can be translated to existing human therapies by incorporating specific, regulated series proteases and antimicrobial peptides at the sites of diabetic ulcers or skin grafts for more efficient wound healing,” said Patterson. She said her team’s results might also have application to treating chronic skin diseases such as psoriasis, severe dry skin and eczema in which levels of these enzymes are known to be abnormal. The PLoS ONE paper can be accessed online after the embargo.
Funding for the study was provided by the National Institutes of Health (GM077197 and HD28315), a Developmental Biology of Neural Diseases Training grant, the Ray Thomas Edwards Fellowship and the family of Herbert Stern.
British Pharmacological Society’s Drug Discovery of the Year 2018 AnnouncedNews
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories ForwardNews
First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.READ MORE
What Does the Future of Vaccines and Immunotherapy Look Like?News
Innovative biomaterials could enhance vaccines against HIV and other infectious diseases and immunotherapies for patients with cancer or dampen responses in autoimmune disorders, allergies and transplanted organ recipients. A review of these efforts was recently released.READ MORE